Cherkasov A - Search Results

1

Identification of novel androgen receptor antagonists using structure- and ligand-based methods.

Li H, Ren X, Leblanc E, Frewin K, Rennie PS, Cherkasov A. Li H, et al. Among authors: cherkasov a. J Chem Inf Model. 2013 Jan 28;53(1):123-30. doi: 10.1021/ci300514v. Epub 2013 Jan 16. J Chem Inf Model. 2013. PMID: 23278403

2

'Inductive' charges on atoms in proteins: comparative docking with the extended steroid benchmark set and discovery of a novel SHBG ligand.

Cherkasov A, Shi Z, Li Y, Jones SJ, Fallahi M, Hammond GL. Cherkasov A, et al. J Chem Inf Model. 2005 Nov-Dec;45(6):1842-53. doi: 10.1021/ci0498158. J Chem Inf Model. 2005. PMID: 16309292

3

Can 'Bacterial-Metabolite-Likeness' model improve odds of 'in silico' antibiotic discovery?

Cherkasov A. Cherkasov A. J Chem Inf Model. 2006 May-Jun;46(3):1214-22. doi: 10.1021/ci050480j. J Chem Inf Model. 2006. PMID: 16711741

4

Comparative QSAR- and fragments distribution analysis of drugs, druglikes, metabolic substances, and antimicrobial compounds.

Karakoc E, Sahinalp SC, Cherkasov A. Karakoc E, et al. Among authors: cherkasov a. J Chem Inf Model. 2006 Sep-Oct;46(5):2167-82. doi: 10.1021/ci0601517. J Chem Inf Model. 2006. PMID: 16995747

5

Using molecular docking, 3D-QSAR, and cluster analysis for screening structurally diverse data sets of pharmacological interest.

Santos-Filho OA, Cherkasov A. Santos-Filho OA, et al. Among authors: cherkasov a. J Chem Inf Model. 2008 Oct;48(10):2054-65. doi: 10.1021/ci8001952. Epub 2008 Sep 24. J Chem Inf Model. 2008. PMID: 18816024

6

Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening.

Axerio-Cilies P, Lack NA, Nayana MR, Chan KH, Yeung A, Leblanc E, Guns ES, Rennie PS, Cherkasov A. Axerio-Cilies P, et al. Among authors: cherkasov a. J Med Chem. 2011 Sep 22;54(18):6197-205. doi: 10.1021/jm200532b. Epub 2011 Aug 29. J Med Chem. 2011. PMID: 21846139

7

Targeting the binding function 3 (BF3) site of the human androgen receptor through virtual screening.

Lack NA, Axerio-Cilies P, Tavassoli P, Han FQ, Chan KH, Feau C, LeBlanc E, Guns ET, Guy RK, Rennie PS, Cherkasov A. Lack NA, et al. Among authors: cherkasov a. J Med Chem. 2011 Dec 22;54(24):8563-73. doi: 10.1021/jm201098n. Epub 2011 Nov 18. J Med Chem. 2011. PMID: 22047606 Free PMC article.

8

Targeting the binding function 3 (BF3) site of the androgen receptor through virtual screening. 2. development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole derivatives.

Munuganti RS, Leblanc E, Axerio-Cilies P, Labriere C, Frewin K, Singh K, Hassona MD, Lack NA, Li H, Ban F, Tomlinson Guns E, Young R, Rennie PS, Cherkasov A. Munuganti RS, et al. Among authors: cherkasov a. J Med Chem. 2013 Feb 14;56(3):1136-48. doi: 10.1021/jm3015712. Epub 2013 Jan 18. J Med Chem. 2013. PMID: 23301637

9

A non-synonymous coding variant (L616F) in the TLR5 gene is potentially associated with Crohn's disease and influences responses to bacterial flagellin.

Sheridan J, Mack DR, Amre DK, Israel DM, Cherkasov A, Li H, Grimard G, Steiner TS. Sheridan J, et al. Among authors: cherkasov a. PLoS One. 2013 Apr 11;8(4):e61326. doi: 10.1371/journal.pone.0061326. Print 2013. PLoS One. 2013. PMID: 23593463 Free PMC article.

10

Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1).

Reipas KM, Law JH, Couto N, Islam S, Li Y, Li H, Cherkasov A, Jung K, Cheema AS, Jones SJ, Hassell JA, Dunn SE. Reipas KM, et al. Among authors: cherkasov a. Oncotarget. 2013 Feb;4(2):329-45. doi: 10.18632/oncotarget.834. Oncotarget. 2013. PMID: 23593654 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters